Cargando…
Nintedanib in the management of idiopathic pulmonary fibrosis: clinical trial evidence and real-world experience
Idiopathic pulmonary fibrosis (IPF) is a fibrotic interstitial lung disease associated with significant morbidity and mortality. Previously, IPF has been managed using immunosuppressive therapy; however, it has been shown that this is associated with increased mortality. In the last 5 years, two dis...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156214/ https://www.ncbi.nlm.nih.gov/pubmed/30249169 http://dx.doi.org/10.1177/1753466618800618 |